ConductScience.org, home

Gene · 10562

OLFM4: olfactomedin 4

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. OLFM4: olfactomedin 4. Genes, record 10562. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10562

On this page

Gene

Symbol
OLFM4
HGNC
Name
olfactomedin 4
HGNC
NCBI Gene ID
10562
NCBI Gene
HGNC ID
HGNC:17190
HGNC
Ensembl
ENSG00000102837
NCBI Gene
Aliases
GC1, GW112, OLM4, OlfD, UNQ362, bA209J19.1, hGC-1, hOLfD, pDP4
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q6UX06Olfactomedin-45100Ensembl, GeneID, HGNC

Source UniProt

Patents143

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1456497Q6UX06Espacenet
EP 4650780 A22025-11-19430Q6UX06Espacenet
EP 4641201 A22025-10-29301Q6UX06Espacenet
JP 2025147176 A2025-10-069792Q6UX06Espacenet
JP 2025529142 A2025-09-047224Q6UX06Espacenet
US 12371689 B22025-07-297224Q6UX06Espacenet
JP 2025517969 A2025-06-12301Q6UX06Espacenet
JP 2025517970 A2025-06-12430Q6UX06Espacenet
JP 2025028160 A2025-02-289792Q6UX06Espacenet
KR 1020250010750 A2025-01-219792Q6UX06Espacenet

1 to 10 of 143

See all 143 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,472

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleOLFM4 papersNewest fiscal year
ZIAHL006004Olfactomedin 4- a key regulator of human neutrophil function, role in small intestinal adenocarcinoma.122025
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease92025
P30DK034987Center for Gastrointestinal Biology and Disease82025
P30DK034854Integrated Epithelial and Muscosal Biology72025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital72025
P30CA008748Cancer Center Support Grant62025
P30CA016672Cancer Center Support Grant62025
P30DK056338Texas Medical Center Digestive Diseases Center62025
P30DK052574Host-environment interactions in the pathophysiology of digestive disease52025
P30DK058404Molecular and Cellular Basis for Digestive Diseases52025

1 to 10 of 1,472Source NIH's project files

See all 1,472 nih grants

Papers1,996

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Integrative transcriptomic analysis of peripheral blood identifies NETosis-associated programs and a stratified adaptive immune suppression pattern in severe acute pancreatitis.PLoS One202642789536PubTator, text miningPubMed
Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.Comb Chem High Throughput Screen202642734237PubTator, text miningPubMed
Incomplete Intestinal Metaplasia as a High-Risk Clinical Phenotype in Gastric Carcinogenesis: Implications for Surveillance and Management.Digestion202642611800PubTator, text miningPubMed
Novel insights into immunohistochemical analysis of intrahepatic cholangiocarcinoma: ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GalNAc1) as a new marker for large duct type.Virchows Arch202642595919PubTator, text miningPubMed
Neurovascular-Immune Biomarkers in Ménière Disease: Insights From High-Throughput Proteomics.Otol Neurotol202642584982PubTator, text miningPubMed
Identification of Biomarkers and Construction of Predictive Models for Sepsis and Septic Shock.Clin Lab202642411682PubTator, text miningPubMed
Single-Cell Transcriptomic Analysis Identifies an OLFM4-Associated Gastric Cancer Cell State with Palmitoylation-Related Signatures and Altered Metabolic Activities.Biomolecules202642352346PubTator, text miningPubMed
RUNX2 promotes chromatin accessibility and WNT signaling in inflamed intestinal epithelial cells.Mucosal Immunol202642276192PubTator, text miningPubMed
Mass cytometry reveals complex neutrophil heterogeneity in patients with severe sepsis.Intensive Care Med Exp202642274989PubTator, text miningPubMed
Tracing the stemness and malignant transition in a heritable colorectal cancer Lynch Syndrome by single-cell RNA-seq analysis.Front Immunol202642266697PubTator, text miningPubMed

1 to 10 of 1,996

See all 1,996 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10562

GET https://conductscience.org/api/genes/v1/10562/patents?page=2